4//SEC Filing
Cloghessy Paula 4
Accession 0000899243-23-004197
CIK 0001609809other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 5:42 PM ET
Size
8.0 KB
Accession
0000899243-23-004197
Insider Transaction Report
Form 4
Cloghessy Paula
See Remarks
Transactions
- Award
Restricted Stock Units
2023-02-03+47,500→ 47,500 total→ Common Stock (47,500 underlying) - Award
Stock Option (Right to Buy)
2023-02-03+95,000→ 95,000 totalExercise: $5.50Exp: 2033-02-02→ Common Stock (95,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The restricted stock units will vest and settle as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter.
- [F3]The option will vest as to 25% of the shares on February 3, 2024. The remainder of the shares will vest in 12 equal quarterly installments thereafter.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001744682
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 5:42 PM ET
- Size
- 8.0 KB